Malignant Hyperpyrexia Syndrome (Postcataract
Hyperpyrexia Syndrome; Postinduction
Hyperpyrexia Syndrome) 424d38e 424d38e 424d38e 424d38e 424d38e 424d38e
General: Etiology uncertain, but believed to be a secondary response to suxamethonium and halothane used with general anesthesia; high mortality rate of about 70%.
Ocular: Malignant hyperpyrexia following congenital cataract or strabismus surgery under general anesthesia.
Clinical: Rapid elevation of body temperature and vastly enhanced metabolic activity; hyperapnea; tachycardia.
Geeraets WJ. Ocular Syndromes, 3rd ed. Philadelphia: Lea & Febiger, 1976.
Snow JC, Kerman TJ. Malignant hyperpyrexia. EENT Dig 1970; 49:427.
Petersdorf RG. Malignant hyperthermia. In: Isselbacher KJ, ed. Harrisons Principles of Internal Medicine, 13th ed. New York: McGraw-Hill, 1994:2476.
Rosenberg H, Fletcher JE. An update on the malignant hyperthermia syndrome. Ann Acad Med Singapore 1994; 23[6 Suppl]:84-97.
Psittacosis (Ornithosis) [...] |
Thomsen Syndrome (Congenital Myotonia Syndrome; Myotonia Congenita) General: Dominant; inheritance manifesta [...] |
Hyperlipoproteinemia [...] |
Copyright © 2010 - 2024
: eSanatos.com - Reproducerea, chiar si partiala, a materialelor de pe acest site este interzisa!
Informatiile medicale au scop informativ si educational. Ele nu pot inlocui consultul medicului si nici diagnosticul stabilit in urma investigatiilor si analizelor medicale la un medic specialist.
Termeni si conditii - Confidentialitatea datelor - Contact
Despre diseases |
| Alte sectiuni |
|
Ai o problema medicala? |
